Response to: 'Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis' by Dr Akioka

Affiliations

Comment

M W Heijstek et al. Ann Rheum Dis. 2014 Dec.

. 2014 Dec;73(12):e76.

doi: 10.1136/annrheumdis-2014-206446. Epub 2014 Sep 29.

¹ Department of Pediatric Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.

No abstract available

Keywords: Autoimmune Diseases; Juvenile Idiopathic Arthritis; Vaccination.

Comment on

Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study.
Heijstek MW, Scherpenisse M, Groot N, Tacke C, Schepp RM, Buisman AM, Berbers GA, van der Klis FR, Wulffraat NM. Heijstek MW, et al. Ann Rheum Dis. 2014 Aug;73(8):1500-7. doi: 10.1136/annrheumdis-2013-203429. Epub 2013 May 30. Ann Rheum Dis. 2014. PMID: 23723319
Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis.
Akioka S. Akioka S. Ann Rheum Dis. 2014 Dec;73(12):e75. doi: 10.1136/annrheumdis-2014-206426. Epub 2014 Aug 27. Ann Rheum Dis. 2014. PMID: 25165031 No abstract available.